Translational Development Acquisition Corp
NASDAQ:TDAC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/OCF
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Valuation Scenarios
If P/OCF returns to its Industry Average (8.5), the stock would be worth $-0.24 (102% downside from current price).
| Scenario | P/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -384.9 | $10.69 |
0%
|
| Industry Average | 8.5 | $-0.24 |
-102%
|
| Country Average | 13.3 | $-0.37 |
-103%
|
Forward P/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | P/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| US |
T
|
Translational Development Acquisition Corp
NASDAQ:TDAC
|
234.2m USD | -384.9 | 36.8 | |
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
301B USD | 0 | 0 | |
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR | 0 | 0 | |
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD | 45 422.5 | 4 020.7 | |
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
101.6B ZAR | 11.4 | 10.5 | |
| US |
F
|
Fintech Ecosystem Development Corp
NASDAQ:FEXD
|
68.1B USD | -45 994.5 | 38 458.7 | |
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
56.3B USD | 0 | 0 | |
| CH |
G
|
Galderma Group AG
SIX:GALD
|
38.3B CHF | 0 | 0 | |
| US |
|
Coupang Inc
F:788
|
31.5B EUR | 20.5 | 174.8 | |
| US |
|
Symbotic Inc
NASDAQ:SYM
|
35.8B USD | 41.9 | -3 291.8 | |
| US |
R
|
Reddit Inc
NYSE:RDDT
|
30.6B USD | 44.3 | 57.8 |
Market Distribution
| Min | 0 |
| 30th Percentile | 8.8 |
| Median | 13.3 |
| 70th Percentile | 20.1 |
| Max | 3 188 432.5 |
Other Multiples
Translational Development Acquisition Corp
Glance View
Translational Development Acquisition Corp is a US-based company operating in industry. The company is headquartered in New York City, New York. The company went IPO on 2024-12-23. Translational Development Acquisition Corp. is a blank check company. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The firm has not selected any specific business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The firm may pursue an acquisition opportunity in any business, industry, sector or geographical location. The firm intends to focus on industries that complement its management team’s background, and to capitalize on the ability of its management team to identify and acquire a business. The firm has neither engaged in any operations nor generated any revenues.
